4
Total investments
0
Early stage
0
Mid stage
1
Late stage
8y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Observer
Jul 2019
PredictImmune develops pioneering tools for guiding personalised treatment options in immune-mediated diseases such as inflammatory bowel disease (IBD).
Based on world-leading research at Cambridge University, UK, we are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payers all recognise the value of such an approach to the management of inflammatory bowel disease (IBD).
www.predictimmune.com
Investor
Jun 2018
BGF is the most active and influential investor in small and mid-sized businesses in the UK.
An established and independent company, we have £2.5bn to support a range of growing companies – early-stage, growth-stage and quoted – across every region and sector in the UK and Ireland.
BGF is a minority, non-controlling equity partner with a patient outlook, based on shared, long-term goals with the management teams we back.
With a 150+ strong team, BGF offers an unparalleled international network of business leaders, sector experts and board-level non-executives. We also provide in-house support, including chair and senior executive selection and appointments.
BGF UK: http://www.bgf.co.uk
BGF Ireland: https://www.bgfireland.ie/
Experience · 5 entries
All (5)
Investments (4)
Board (3)
2021
Board Observer
Aug 2021
For over 25 years, we’ve made nappies that are better for babies, parents and our planet. We’re leading a Reusable Revolution to free the world of single-use nappies, once and for all. With 250 million single-use nappies being thrown away every day, the future were making is getting messier by the minute. Its time to change things.
2019
Board Observer
Jul 2019
PredictImmune develops pioneering tools for guiding personalised treatment options in immune-mediated diseases such as inflammatory bowel disease (IBD).
Based on world-leading research at Cambridge University, UK, we are developing a simple lab test, using a small blood sample, which accurately identifies patients at diagnosis who are at risk of experiencing severe, relapsing disease. These patients are likely to benefit from early biologics therapy. Physicians, patients and payers all recognise the value of such an approach to the management of inflammatory bowel disease (IBD).
www.predictimmune.com
Board Observer
Jan 2019
At Kocho, we believe greatness lies in everyone.
That’s why we exist, to help ambitious companies realise their potential.
By combining the power of Microsoft cloud with identity, mobility, connectivity, and cyber security services, with our team of truly talented people, we take our clients on a journey of secure transformation.
And we’re with you every step of the way. Because the path to greatness isn’t walked alone. We help you adopt and embrace the right technology solutions at the right time.
The result? Sustainable and secure growth that amplifies your business success.
Kocho. Become Greater.
2018
Investor
Jun 2018
BGF is the most active and influential investor in small and mid-sized businesses in the UK.
An established and independent company, we have £2.5bn to support a range of growing companies – early-stage, growth-stage and quoted – across every region and sector in the UK and Ireland.
BGF is a minority, non-controlling equity partner with a patient outlook, based on shared, long-term goals with the management teams we back.
With a 150+ strong team, BGF offers an unparalleled international network of business leaders, sector experts and board-level non-executives. We also provide in-house support, including chair and senior executive selection and appointments.
BGF UK: http://www.bgf.co.uk
BGF Ireland: https://www.bgfireland.ie/
2013
Associate Director Corporate Finance
Oct 2013
When choosing an advisor, you could accept the usual compromises.
Alternatively, you can find people that aren’t afraid to break with the norms to provide a more rewarding experience. With people that leave you feeling smart, not smarting.
The UK member firms of Grant Thornton are part of a global network that employs over 76,000 people in 150 countries. We combine global scale with local insight and understanding to give you the assurance, tax, and advisory services you need to realise your ambitions.
We go beyond business as usual, so you can too. We make business more personal by investing in building relationships. Whether you’re growing in one market or many, you consistently get a great service you can trust. We work at a pace that matters – yours – bringing both flexibility and rigour. We celebrate fresh thinking and diverse perspectives to bring you proactive insights and positive progress.
Ready to go beyond? Visit our website for insight on what we can offer you.
© 2025 Grant Thornton UK LLP and Grant Thornton UK Advisory & Tax LLP. All rights reserved.
‘Grant Thornton’ refers to the brand under which the Grant Thornton member firms provide assurance, tax and advisory services to their clients and/or refers to one or more member firms, as the context requires. Grant Thornton UK LLP and Grant Thornton Advisory & Tax LLP are member firms of Grant Thornton International Ltd (GTIL). GTIL and the member firms are not a worldwide partnership. GTIL and each member firm is a separate legal entity. Services are delivered by the member firms. GTIL does not provide services to clients. GTIL and its member firms are not agents of, and do not obligate, one another and are not liable for one another’s acts or omissions. This publication has been prepared only as a guide. No responsibility is accepted by us for loss occasioned to any person acting or refraining from acting as a result of any material in this publication.
Investment activity
2018–2021 · 4 investments
Recent (last 2 years)Earlier
